Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Corcept Therapeutics Inc. buy Canaccord Genuity Group Inc.

Corcept Therapeutics Inc.
Start price
€59.40
20:30 / 50%
Target price
€116.49
28.05.27
Performance (%)
-1.18%
Price
€58.70
22:25
Summary
This prediction is currently active. With a performance of -1.18%, the BUY prediction for Corcept Therapeutics Inc. by Canaccord_Genuity_Gr is down slightly. This prediction currently runs until 28.05.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w
Corcept Therapeutics Inc. -1.18%
iShares Core DAX® 1,76 %
iShares Nasdaq 100 2,29 %
iShares Nikkei 225® 5,32 %
iShares S&P 500 1,25 %

Comments by Canaccord_Genuity_Gr for this prediction

In the thread Corcept Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -1.18%
Target price 116.492
Change
Ends at 28.05.27

Corcept Therapeutics (CORT) had its price target raised by Canaccord Genuity Group Inc. from $110.00 to $135.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat

Canaccord Genuity Group Inc. 
0
Report Share
20:30

Stopped prediction by Canaccord_Genuity_Gr for Corcept Therapeutics Inc.

buy
Corcept Therapeutics Inc.

Start price
Target price
Perf. (%)
€33.55
26.03.26
€95.16
26.03.27
74.96%
22:25

Canaccord Genuity Group Inc. 
26.03.26 50%
buy
Corcept Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.83
08.03.23
€30.31
08.03.24
7.94%
09.03.24

Canaccord Genuity Group Inc. 
08.03.23 50%